NUA SURGICAL Revenue and Competitors

A multi-award winning Irish company innovating in women's health. \nNua Surgical was developed out of BioInnovate Ireland and is dedicated to innovating in Women's Health. The team have developed and patented the SteriCISION C-Section Retractor to answer unmet clinical needs in obstetric surgery. Established in 2018, the company has progressed through various funding rounds and is now backed by some of the most credible healthcare investors. \n\nBrief Overview of Achievements:\n\n𝟮𝟬𝟭𝟴\n- Our founding team were awarded an Enterprise Ireland Commercialisation Fund to bring the project from early stage concept to commercialisation.  This was based at the University of Galway.\n\n𝟮𝟬𝟭𝟵\n- Nua Surgical was chosen as one of seven start-ups between Ireland and the U.S. to participate in the Blackstone-backed accelerator 'LaunchPad Lift' powered by Techstars.\n- Our CEO was named 'Best Senior Entrepreneur' at the EIT Health Alumni Needs-Led Innovation Showcase in Lisbon, Portugal.\n\n𝟮𝟬𝟮𝟬\n- One of 16 UK and Ireland Start-ups to be awarded €40,000 through the EIT Health Headstart Programme.\n- One of 15 winners for the national HIHI Healthcare Innovation Call 2020.  \n- Winner of the InterTrade Ireland Seedcorn Competition, securing €100,000.  \n\n𝟮𝟬𝟮𝟭\n- Winners of the Global Healthy Mom and Baby Innovation Competition 2.0, run by Parkview Health and MATTER (USA). \n\n𝟮𝟬𝟮𝟮\n- Won MedTech category of the 'Global Tech For Good' Competition run by Empact Ventures, Hays and the NIHR.\n- Winner of the MedTech Category at the National Start-Up Awards, followed by overall Grand-Prix Winner at the famous Dublin City Hall ceremony. \n\n𝟮𝟬𝟮𝟯\n- The only non-US company to participate in Cohort 15 of the prestigious Texas Medical Center HealthTech Accelerator.\n- 1 of 8 Irish finalists for the KPMG Global Tech Innovation Awards.\n- 'Emerging MedTech Company of the Year' at the prestigious Irish MedTech Awards.\n- Double winners at the 2023 National HealthTech Innovation Awards.